Francesc J Moreso

1 Introduction Over the last decades, the prevalence of older people with End Stage Renal Disease (ESRD) has increased with the rise in life expectancy. This shift has consequently changed transplantation demographics, increasing the number of elderly patients on organ waiting lists [1]. While advanced age is no longer an absolute contraindication for transplantation, the associated comorbidities and surgical risks can pose challenges in accessing this therapeutic option for older patients [2].

4. Discussion We report a large experience of HCV seronegative recipients receiving kidneys from HCV positive donors, either non-viremic or viremic. In recipients from non-viremic donors, active surveillance of viral transmission was pursued; in recipients from viremic donors, peri-transplant treatment with DAA was started. Both cohorts were not different in their baseline characteristics and patients and graft outcomes were not significantly different.

Health-related behaviours and psychological distress were examined after kidney transplantation. Patients were evaluated at 1?month, 6?months and 1?year after transplantation. Participants completed the Healthy Behaviours Questionnaire and the Hospital Anxiety and Depression Scale. No significant differences in Healthy Behaviours Questionnaire’s total score and psychological comorbidity were observed at three time points.